Chief Financial Officer
Philadelphia, Pa, Us
CFO of Elixir Rx Solutions• Elixir (formerly Envision) is an innovative healthcare services and information technology company, with a focus on pharmacy benefit management (PBM), insurance products, software and information technology services, mail-order pharmacy and specialty pharmacy operations• CFO with full P&L, cash flow, balance sheet and capital structure responsibility for all operations and subsidiaries• Experience includes private equity, mergers & acquisitions, strategic planning, accounting, finance, treasury, underwriting, statutory financial statements, customer negotiations & contracting, vendor negotiations & contracting, human resources, information technology, tax planning, SOX, internal audit, SEC filings and board of directors reportingSelected Accomplishments:• Increased net revenue by 1,000% (from $50 million to $500 million)• Increased EBITDA by 1,700% (from $11 million to $188 million) through both organic growth and strategic acquisitions• Negotiated and structured sale of Envision to Rite Aid for $2 billion• Negotiated and structured private equity transaction with TPG Capital, in which TPG acquired 65% of Envision for $1 billion• Negotiated and structured 5 credit agreements with banks, including expansion of 1st lien and 2nd lien term loans and revolver to support acquisitions• Negotiated and structured $500 million accounts receivable securitization transaction• Negotiated and structured 2 reinsurance agreements• Restructured operations of major subsidiary, and converted subsidiary from a loss to significant positive EBITDA• Negotiated and structured 3 strategic acquisitions (including rollover equity reinvestment by sellers) with total purchase prices of $300 million, and 1 joint venture• Managed integration teams for 3 acquired companies, including: treasury and cash management, accounting systems, operating systems, procurement and employee benefitsMember of the Board of Directors of HolaDoctor, Inc.